Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Nicolas

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Experiments in Fluids|February 27, 2023
Interaction of a droplet spray with a turbulent plane air jet impacting a wall: Application to the confinement of atmospheres contaminated with particles by air curtainSyphax Ikardouchene, Stéphane Delaby, Xavier Nicolas
Presse Medicale (Paris, France : 1983)|April 3, 2007
[Shigellosis or bacillary dysentery]Xavier Nicolas, Hervé Granier, Patrick Le Guen
Presse Medicale (Paris, France : 1983)|September 25, 2003
[Severe autoimmune thrombopenia following anti-influenza vaccination]Hervé Granier, Xavier Nicolas, Jean-Pierre Laborde, et al.
Presse Medicale (Paris, France : 1983)|January 8, 2008
[Schwannoma of the cauda equina]Xavier Nicolas, Jean Rousset, Hervé Granier, et al.
Breast Cancer (Tokyo, Japan)|March 28, 2023
Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2)Kenji Tamura, Toru Mukohara, Kan Yonemori, et al.
Travel Medicine and Infectious Disease|August 6, 2013
Crossing the Gulf of Aden: cutaneous infections in African migrant shipwreck survivorsFabrice Simon, Philippe Gautret, Xavier Nicolas, et al.
Clinical Pharmacokinetics|May 5, 2018
Population Pharmacokinetic/Pharmacodynamic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using an Indirect Response Model to Predict Low-Density Lipoprotein Cholesterol Lowering: Support for a Biologics License Application Submission: Part IIXavier Nicolas, Nassim Djebli, Clémence Rauch, et al.
Clinical Pharmacology in Drug Development|September 14, 2023
Pharmacokinetics of Alglucosidase Alfa Manufactured at the 4000-L Scale in Participants with Pompe Disease: A Phase 3/4 Open-Label StudyXavier Nicolas, Fabrice Hurbin, Magali Periquet, et al.
Presse Medicale (Paris, France : 1983)|November 26, 2011
[Medication reconciliation: an innovative experience in an internal medicine unit to decrease errors due to inacurrate medication histories]Maud Pérennes, Axel Carde, Xavier Nicolas, et al.
Annales De Biologie Clinique|October 12, 2013
[A melanesian smile…]Catherine Désidéri-Vaillant, Laurence Di Costanzo, Julia Di Filipo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Experiments in Fluids|February 27, 2023
Interaction of a droplet spray with a turbulent plane air jet impacting a wall: Application to the confinement of atmospheres contaminated with particles by air curtainSyphax Ikardouchene, Stéphane Delaby, Xavier Nicolas
Presse Medicale (Paris, France : 1983)|April 3, 2007
[Shigellosis or bacillary dysentery]Xavier Nicolas, Hervé Granier, Patrick Le Guen
Presse Medicale (Paris, France : 1983)|September 25, 2003
[Severe autoimmune thrombopenia following anti-influenza vaccination]Hervé Granier, Xavier Nicolas, Jean-Pierre Laborde, et al.
Presse Medicale (Paris, France : 1983)|January 8, 2008
[Schwannoma of the cauda equina]Xavier Nicolas, Jean Rousset, Hervé Granier, et al.
Breast Cancer (Tokyo, Japan)|March 28, 2023
Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2)Kenji Tamura, Toru Mukohara, Kan Yonemori, et al.
Travel Medicine and Infectious Disease|August 6, 2013
Crossing the Gulf of Aden: cutaneous infections in African migrant shipwreck survivorsFabrice Simon, Philippe Gautret, Xavier Nicolas, et al.
Clinical Pharmacokinetics|May 5, 2018
Population Pharmacokinetic/Pharmacodynamic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using an Indirect Response Model to Predict Low-Density Lipoprotein Cholesterol Lowering: Support for a Biologics License Application Submission: Part IIXavier Nicolas, Nassim Djebli, Clémence Rauch, et al.
Clinical Pharmacology in Drug Development|September 14, 2023
Pharmacokinetics of Alglucosidase Alfa Manufactured at the 4000-L Scale in Participants with Pompe Disease: A Phase 3/4 Open-Label StudyXavier Nicolas, Fabrice Hurbin, Magali Periquet, et al.
Presse Medicale (Paris, France : 1983)|November 26, 2011
[Medication reconciliation: an innovative experience in an internal medicine unit to decrease errors due to inacurrate medication histories]Maud Pérennes, Axel Carde, Xavier Nicolas, et al.
Annales De Biologie Clinique|October 12, 2013
[A melanesian smile…]Catherine Désidéri-Vaillant, Laurence Di Costanzo, Julia Di Filipo, et al.
Pageof 2